🔎 Trials Near Me

Home › Wilms Tumor › Illinois › Chicago

Wilms Tumor clinical trials in Chicago, IL

4 studies for Wilms Tumor are looking for participants at sites in and around Chicago (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell Tumor

RecruitingPhase 2
  • University of Chicago Comprehensive Cancer Center, Chicago
Ages 12 to 39 · All sexes · Updated Sep 29, 2026 · NCT04616560

A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT

RecruitingPhase 2
  • Lurie Children's Hospital-Chicago, Chicago
  • University of Chicago Comprehensive Cancer Center, Chicago
Up to age 30 · All sexes · Updated Aug 25, 2026 · NCT04322318

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

RecruitingPhase 1/2
  • Lurie Children's Hospital-Chicago, Chicago
12 Months – 30 Years · All sexes · Updated Aug 25, 2026 · NCT04851119

A Study of Selinexor in People With Wilms Tumors and Other Solid Tumors

RecruitingPhase 2
  • Ann & Robert H. Lurie Children'S Hospital of Chicag, Chicago
12 Months · All sexes · Updated May 6, 2026 · NCT05985161

About Wilms Tumor

Wilms' Tumor (or Nephroblastoma) is a rare type of cancer that affects one or both kidneys. Find a list of symptoms and treatments associated

More about Wilms Tumor on MedlinePlus

Wilms Tumor trials in other cities

Other studies in Chicago

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.